A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Northwestern University
Northwestern University
Northwestern University
M.D. Anderson Cancer Center
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
UNC Lineberger Comprehensive Cancer Center
Stanford University
Georgetown University